We are committed to
Doing everything to help patients feel stronger and get better.
Our Goal
We are on a mission to improve availability, reliability and sustainability of generic medicines. Located at the Leiden Bio Science Park, the Netherlands, we drive innovation in the generics industry together with our partners.
In our work, we are committed to meeting the evolving needs of our clients by using our experience and expertise to always deliver the best possible services.
We drive innovation in the generics industry
to become better, more reliable and more sustainable.
Purpose
We all wish to enjoy healthy lives. Sometimes, illness interferes with our ambition.
This is where our work can make a difference: Our purpose is to help patients feel stronger and get better.
We do this by delivering high-quality medicines and services: reliable, sustainable and affordable.
Innovation
We are convinced that innovation is the key to become better and do better. Through innovation we can solve many of today’s healthcare challenges.
Knowledge preservation and maintaining production of generic medicine in the European Union is vital for this.
We engage with stakeholders and partners to drive innovation in the generics industry. Our location at the Leiden Bio Science Park, the Netherlands is ideal for this.
We actively pioneer new tableting technologies. For this we also support Dutch academia, knowledge centres and other stakeholders in knowledge building and preservation.
Our Clinic
Our Clinic is a chance for students and interested people to learn more about the pharmaceutical industry. During the half day program you will learn more about the pharmaceutical industry and the laws that govern it. You will see how GMP (Good Manufacturing Practices) works in practice and what information is needed to register a new drug.
The clinic concludes with a tour of our factory, warehouse and laboratory, which gives you a good idea of how our medicines are made according to GMP guidelines.
Latest news and stories



Trustee InnoGenerics is looking for opportunities to maintain essential generic drug production in the Netherlands
Press release Leiden, December 14, 8:30 p.m On December 13th, 2022, the court of The Hague appointed Henri Bentfort van Valkenburg as trustee of the



Curator InnoGenerics zoekt mogelijkheden om essentiële generieke geneesmiddelenproductie in Nederland te behouden
Persbericht Leiden, 14 december 20.30 uur Op 13 december 2022 heeft de rechtbank Den Haag Henri Bentfort van Valkenburg benoemd als curator van de failliete


UN Global Compact
We are proud to be a signatory to the UN Global Compact since this year. We have identified six UN Sustainable Development Goals where our